Wealthspire Advisors, L.P. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Wealthspire Advisors, L.P. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$82,000
+60.8%
656
+75.9%
0.01%
+20.0%
Q4 2018$51,000
-51.4%
373
-2.4%
0.01%
-44.4%
Q3 2018$105,000
+34.6%
382
+1.6%
0.01%
+28.6%
Q2 2018$78,000
+50.0%
376
+19.7%
0.01%
+40.0%
Q1 2018$52,000
+48.6%
314
+21.2%
0.01%
+66.7%
Q4 2017$35,000
+29.6%
259
+30.8%
0.00%0.0%
Q3 2017$27,000
+440.0%
198
+340.0%
0.00%
+200.0%
Q2 2017$5,000450.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders